BIOMAT Database Logo BIOMAT Database Logo

[Detection of HIV antibodies in saliva in a Parisian screening center]. 1994

O Chassany, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005602 France A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris. Corsica,Saint Pierre and Miquelon,Miquelon and Saint Pierre,Miquelon and St. Pierre,St. Pierre and Miquelon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

O Chassany, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
Detection of antibodies to HIV in saliva.
January 1999, The National medical journal of India,
O Chassany, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
Detection of anti-HIV antibodies in saliva.
April 1993, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
O Chassany, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
[Detection of HIV virus antibodies in saliva].
September 1995, Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne,
O Chassany, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
Detection of HIV antibodies in saliva and its implications.
January 1995, Indian journal of dental research : official publication of Indian Society for Dental Research,
O Chassany, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
[Detection of antibodies to HIV and HIV-genes in saliva and urine].
September 1993, Nihon rinsho. Japanese journal of clinical medicine,
O Chassany, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
Detection of antibodies to HIV-1 in serum and saliva.
April 1997, The Journal of the Association of Physicians of India,
O Chassany, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
Detection of HIV antibodies in saliva as a tool for epidemiological studies.
September 1992, AIDS (London, England),
O Chassany, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
[Detection of HIV antibodies in saliva using a rapid diagnostic immunoenzyme assay].
July 1994, Revista clinica espanola,
O Chassany, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
Comparison of two assays for detection of HIV antibodies in saliva.
April 1995, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
O Chassany, and M C Mazeron, and J Cervoni, and V Grégoire, and M J Sanson-Le-Pors, and C Caulin
Antibodies to HIV in saliva.
April 1989, The New England journal of medicine,
Copied contents to your clipboard!